Sylogent

Name

Sylogent

Website

https://sylogent.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

Sylogent is a privately held Newtown, US-based software vendor founded in 1999 that delivers software solutions to pharmaceutical, biotech, and medical device companies. It operates with 11–50 employees, though its public web presence is currently inactive.

Ownership category

akta.pro rank

Product category

Pharmaceutical & Biotech Software

NAICS

Software Publishers (5132)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

akta.pro secondary industries

Regulatory Information Management (RIM) & Submission Publishing Software (HLAGAJAL), Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

Keywords

• Pharmaceutical software
• Biotech software
• Medical device software
• Life sciences software
• Regulated industry software

Headquarters

HQ city

Newtown

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales

Core offering

Sylogent delivers software solutions to a variety of pharmaceutical, biotech, and medical device companies. The company operates as a private, for-profit software provider serving the life sciences sector and was founded in 1999 with 11-50 employees, headquartered in Newtown, United States.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Veeva Systems: Veeva is the dominant cloud software platform serving the global life sciences industry, with deep coverage of clinical, regulatory, quality, and commercial workflows for pharma, biotech, and medical device companies. It is the obvious broad incumbent competitor and consolidator in the exact category Sylogent addresses.
• Medidata Solutions (Dassault Systèmes): Medidata provides the leading electronic data capture (EDC), CTMS, and eCOA platform for clinical trials — directly overlapping with where a small life sciences software firm like Sylogent historically would have competed. As part of Dassault Systèmes, it represents the scaled platform incumbent in clinical trial informatics.
• IQVIA (Clinical & Technology Solutions): IQVIA combines CRO services with proprietary clinical and real-world evidence software platforms sold to pharma and biotech. Its technology offerings overlap Sylogent's claimed niche and it is a significant buyer of smaller technology assets in this category.
• Oracle Health Sciences (Clinical One / InForm): Oracle's Health Sciences unit offers EDC (InForm), CTMS, and clinical trial analytics — the historical same-product category Sylogent would have targeted — and competes for the same mid-market pharma/biotech accounts. It is a broad incumbent alternative buyer.
• Clario (formerly ERT / Bioclinica): Clario (formed from the merger of ERT and Bioclinica) provides eCOA, cardiac safety, medical imaging, and clinical trial endpoint technology — directly relevant comparable for a small clinical-trial-focused software firm serving pharma/biotech.
• Veeva Vault RIM / DXC Technology Life Sciences: DXC Technology operates a life sciences practice that historically delivered and supported regulated software implementations for pharma and biotech, making it a broad incumbent service and platform competitor in the same customer set Sylogent targets.

Direct peers

• ArisGlobal: ArisGlobal builds life sciences software spanning regulatory information management (RIM), pharmacovigilance, clinical trial management, and quality — directly overlapping the pharma/biotech software niche Sylogent claims to serve. Mid-size, private, and product-focused makes ArisGlobal the most directly comparable specialized peer.
• Certara: Certara provides regulatory and scientific software (including submission publishing, RIM, and biosimulation tools) to pharma and biotech — a near-direct functional overlap with the software niche Sylogent addresses. Public company status makes it a useful comparable for valuation benchmarking.
• BioVectra (now part of Agilent-affiliated CDMO) / Dotmatics: Dotmatics delivers scientific data management and informatics platforms used by pharma and biotech research organizations — overlapping with the broader life sciences software category Sylogent addresses, particularly around scientific data and R&D workflows.

Emerging players

• BioClin (Cognizant Life Sciences): Originally a focused clinical trial technology vendor (BioClin), now embedded within Cognizant's life sciences practice — illustrates the historical acquirer pattern for niche life sciences software assets like Sylogent. Useful as a comparable exit/buyer archetype.

Market position

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sylogent